Telix Submits NDA for New Prostate Cancer Imaging Agent
Go back to Telix Submits NDA for New Prostate Cancer Imaging Agent| TRANS-LUX CORPORATION (NASDAQ: TLX) | Delayed: 10.58 -0.07 (0.66%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $10.65 | 52 Week High | $2.18 | |||
| Open | $10.52 | 52 Week Low | $0.30 | |||
| Day High | $10.59 | P/E | N/A | |||
| Day Low | $10.43 | EPS | $-3.32 | |||
| Volume | 171,970 | |||||



